Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC
NCT06639971
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma (HCC)
Sponsor
Shanghai Zhongshan Hospital